Publisher · 3 documents · 4 figures
GSK
4 verified figures from 3 publications by GSK, a company. Every figure links to the document and sentence it came from.
Data points
4
Documents
3
Indicators
4
Regions
2
Publisher type
Company
Documents used
Every publication we have taken a number from, with the date we read it and the link status at that time.
| Document | Type | Retrieved | Link | Data points |
|---|---|---|---|---|
| GSK to advance mRNA seasonal flu vaccine candidate to phase III following positive phase II data Licence: See source | Press release | 15 Sep 2026 | Reachable | 2 |
| GSK to establish new flagship R&D centre on Cambridge Biomedical Campus, UK Licence: See source | Press release | 17 Sep 2026 | Reachable | 1 |
| GSK delivers strong Q2 core results performance and continued momentum. Plans announced to accelerate R&D and late-stage pipeline portfolio. Expect 20+ phase III trial starts in 2026 Licence: See source | Press release | 17 Sep 2026 | Reachable | 1 |
Measures from this publisher
Every measure taken from GSK, with its latest value and trend. Each value opens its record.
Market size and output 1
People and employment 1
Other measures 2
4 measures. Each name opens the full series; each value opens the record with its source evidence.
Cite this page
Data on this page is published under CC BY 4.0. Credit GSK as the original publisher; each record page carries its own citation.
GSK. Retrieved from StatOrigin: https://statorigin.org/sources/gsk
Related
Industries using this source
Last verified 27 September 2026. Link status is rechecked weekly.